Jeevan Scientific Technology informs about company updates

21 Dec 2016 Evaluate

Jeevan Scientific Technology has informed that the Company’s Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the ‘Office of Drug Control General, India (DCGI)’ on 16-December-2016 for a period of Three years. This Centre having four independent clinics having a total capacity of 132 beds will facilitate end-to-end Bioequivalence studies by Jeevan Scientific Technology.

The above information is a part of company’s filings submitted to BSE.

Jeevan Scientific Share Price

66.98 -1.36 (-1.99%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 3206.70
Infosys 1689.40
HCL Tech. 1698.90
Wipro 267.25
Tech Mahindra 1670.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×